Table of Contents Author Guidelines Submit a Manuscript
Disease Markers
Volume 2016, Article ID 1821596, 7 pages
http://dx.doi.org/10.1155/2016/1821596
Research Article

Effects of Ramipril and Telmisartan on Plasma Concentrations of Low Molecular Weight and Protein Thiols and Carotid Intima Media Thickness in Patients with Chronic Kidney Disease

1Department of Biomedical Sciences, University of Sassari, 07100 Sassari, Italy
2Department of Clinical Pharmacology, School of Medicine, Flinders University, Bedford Park, SA 5042, Australia
3Department of Surgical, Microsurgical and Medical Sciences, University of Sassari, 07100 Sassari, Italy

Received 18 May 2016; Revised 28 June 2016; Accepted 29 June 2016

Academic Editor: Manfredi Rizzo

Copyright © 2016 Angelo Zinellu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. D. Toto, “Treatment of hypertension in chronic kidney disease,” Seminars in Nephrology, vol. 25, no. 6, pp. 435–439, 2005. View at Publisher · View at Google Scholar · View at Scopus
  2. T. Ohara, Y. Kokubo, K. Toyoda et al., “Impact of chronic kidney disease on carotid atherosclerosis according to blood pressure category: the suita study,” Stroke, vol. 44, no. 12, pp. 3537–3539, 2013. View at Publisher · View at Google Scholar · View at Scopus
  3. S. Zoungas, J. D. Cameron, P. G. Kerr et al., “Association of carotid intima-medial thickness and indices of arterial stiffness with cardiovascular disease outcomes in CKD,” American Journal of Kidney Diseases, vol. 50, no. 4, pp. 622–630, 2007. View at Publisher · View at Google Scholar · View at Scopus
  4. A. Szarejko-Paradowska, A. Gluba-Brzózka, R. Pietruszyński, and J. Rysz, “Assessment of the relationship between selected cardiovascular risk factors and the indices of intima-media thickness and coronary artery calcium score in various stages of chronic kidney disease,” International Urology and Nephrology, vol. 47, no. 12, pp. 2003–2012, 2015. View at Publisher · View at Google Scholar · View at Scopus
  5. J. Kotur-Stevuljević, A. Peco-Antić, S. Spasić et al., “Hyperlipidemia, oxidative stress, and intima media thickness in children with chronic kidney disease,” Pediatric Nephrology, vol. 28, no. 2, pp. 295–303, 2013. View at Publisher · View at Google Scholar · View at Scopus
  6. F. Turnbull, “Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials,” The Lancet, vol. 362, no. 9395, pp. 1527–1535, 2003. View at Publisher · View at Google Scholar · View at Scopus
  7. P. Ruggenenti, A. Perna, G. Gherardi, F. Gaspari, R. Benini, and G. Remuzzi, “Renal function and requirement for dialysis in chronic nephropathy patients on long-term ramipril: REIN follow-up trial,” The Lancet, vol. 352, no. 9136, pp. 1252–1256, 1998. View at Publisher · View at Google Scholar · View at Scopus
  8. P. Ruggenenti, A. Perna, G. Gherardi et al., “Renoprotective properties of ACE-inhibition in non-diabetic nephropathies with non-nephrotic proteinuria,” The Lancet, vol. 354, no. 9176, pp. 359–364, 1999. View at Publisher · View at Google Scholar · View at Scopus
  9. J. F. Mann, R. E. Schmieder, M. McQueen et al., “Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled trial,” The Lancet, vol. 372, no. 9638, pp. 547–553, 2008. View at Publisher · View at Google Scholar · View at Scopus
  10. S. Koulouris, P. Symeonides, K. Triantafyllou et al., “Comparison of the effects of Ramipril versus Telmisartan in reducing serum levels of high-sensitivity C-reactive protein and oxidized low-density lipoprotein cholesterol in patients with type 2 diabetes mellitus,” The American Journal of Cardiology, vol. 95, no. 11, pp. 1386–1388, 2005. View at Publisher · View at Google Scholar · View at Scopus
  11. W. K. C. Lai and M. Y. Kan, “Homocysteine-induced endothelial dysfunction,” Annals of Nutrition and Metabolism, vol. 67, no. 1, pp. 1–12, 2015. View at Publisher · View at Google Scholar · View at Scopus
  12. P. Ganguly and S. F. Alam, “Role of homocysteine in the development of cardiovascular disease,” Nutrition Journal, vol. 14, article 6, 2015. View at Publisher · View at Google Scholar · View at Scopus
  13. N. Jacob, E. Bruckert, P. Giral, M. J. Foglietti, and G. Turpin, “Cysteine is a cardiovascular risk factor in hyperlipidemic patients,” Atherosclerosis, vol. 146, no. 1, pp. 53–59, 1999. View at Publisher · View at Google Scholar · View at Scopus
  14. L. El-Khairy, P. M. Ueland, H. Refsum, I. M. Graham, and S. E. Vollset, “Plasma total cysteine as a risk factor for vascular disease: the European concerted action project,” Circulation, vol. 103, no. 21, pp. 2544–2549, 2001. View at Publisher · View at Google Scholar · View at Scopus
  15. A. Zinellu, G. Loriga, B. Scanu et al., “Increased low-density lipoprotein S-homocysteinylation in chronic kidney disease,” American Journal of Nephrology, vol. 32, no. 3, pp. 242–248, 2010. View at Publisher · View at Google Scholar · View at Scopus
  16. C. Carru, L. Deiana, S. Sotgia, G. M. Pes, and A. Zinellu, “Plasma thiols redox status by laser-induced fluorescence capillary electrophoresis,” Electrophoresis, vol. 25, no. 6, pp. 882–889, 2004. View at Publisher · View at Google Scholar · View at Scopus
  17. W. Liang, C. Y. R. Tan, L. Ang et al., “Ramipril improves oxidative stress-related vascular endothelial dysfunction in db/db mice,” The Journal of Physiological Sciences, vol. 58, no. 6, pp. 405–411, 2008. View at Publisher · View at Google Scholar · View at Scopus
  18. A. Zinellu, C. Carru, F. Galistu et al., “N-methyl-d-glucamine improves the laser-induced fluorescence capillary electrophoresis performance in the total plasma thiols measurement,” Electrophoresis, vol. 24, no. 16, pp. 2796–2804, 2003. View at Publisher · View at Google Scholar · View at Scopus
  19. G. L. Ellman, “Tissue sulfhydryl groups,” Archives of Biochemistry and Biophysics, vol. 82, no. 1, pp. 70–77, 1959. View at Publisher · View at Google Scholar · View at Scopus
  20. Società Italiana di Diagnostica Vascolare, “Operative procedures for vascular diagnostic investigations. Guidelines of the Italian Society of Vascular Diagnosis (GUIV),” Minerva Cardioangiologica, vol. 48, no. 9, pp. 303–355, 2000. View at Google Scholar
  21. P.-J. Touboul, M. G. Hennerici, S. Meairs et al., “Mannheim intima-media thickness consensus,” Cerebrovascular Diseases, vol. 18, no. 4, pp. 346–349, 2004. View at Publisher · View at Google Scholar · View at Scopus
  22. P. Susantitaphong, K. Sewaralthahab, E. M. Balk, S. Eiam-Ong, N. E. Madias, and B. L. Jaber, “Efficacy and safety of combined vs. single renin-angiotensin-aldosterone system blockade in chronic kidney disease: a meta-analysis,” American Journal of Hypertension, vol. 26, no. 3, pp. 424–441, 2013. View at Publisher · View at Google Scholar · View at Scopus
  23. F. Catapano, P. Chiodini, L. De Nicola et al., “Antiproteinuric response to dual blockade of the renin-angiotensin system in primary glomerulonephritis: meta-analysis and metaregression,” American Journal of Kidney Diseases, vol. 52, no. 3, pp. 475–485, 2008. View at Publisher · View at Google Scholar · View at Scopus
  24. S. Yusuf, K. K. Teo, J. Pogue et al., “Telmisartan, ramipril, or both in patients at high risk for vascular events,” The New England Journal of Medicine, vol. 358, no. 15, pp. 1547–1559, 2008. View at Publisher · View at Google Scholar · View at Scopus
  25. S. W. Tobe, C. M. Clase, P. Gao et al., “Cardiovascular and renal outcomes with telmisartan, ramipril, or both in people at high renal risk: results from the ONTARGET and TRANSCEND studies,” Circulation, vol. 123, no. 10, pp. 1098–1107, 2011. View at Publisher · View at Google Scholar · View at Scopus
  26. R. Rossi, D. Giustarini, A. Milzani, and I. Dalle-Donne, “Cysteinylation and homocysteinylation of plasma protein thiols during ageing of healthy human beings,” Journal of Cellular and Molecular Medicine, vol. 13, no. 9, pp. 3131–3140, 2009. View at Publisher · View at Google Scholar · View at Scopus
  27. M. H. El Samahy, R. M. Matter, O. I. Youssef, M. A. Shams El Din El Telbany, and N. A. Kamal, “Relation between carotid intima media thickness and oxidative stress markers in type 1 diabetic children and adolescents,” Journal of Diabetes and Metabolic Disorders, vol. 12, no. 1, article 50, 2013. View at Publisher · View at Google Scholar · View at Scopus